Additional file 2 of TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Head and Neck Cancer Studies
Nonmelanoma Skin Cancer Studies
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026
- Language
- EN